Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
NGS
Poly(A) selection vs rRNA depletion: guide for picking the right upstream method.
August 25, 2025 -
3 min read
Reproductive Health
Building tomorrow - the professional journey of an SMA scientist.
August 25, 2025 -
2 min read
Neurodegeneration
Validating brain-penetrating nanobodies with HTRF GPCR second messenger and receptor binding assays.
August 20, 2025 -
5 min read
Reproductive Health
Uniting for early detection: the role of Revvity in DMD screening.
August 16, 2025 -
6 min read
Cancer
How conditional bispecific antibodies are advancing precision immunotherapy.
August 14, 2025 -
2 min read
Cancer
Scaling up oligonucleotide discovery: accelerating therapeutic lead identification from months to weeks.
August 6, 2025 -
3 min read
Functional Genomic Screening
Building on Ambros and Ruvkun's Nobel-Winning studies with Revvity’s microRNA toolkit.
July 30, 2025 -
3 min read
Disease Research
What to consider when choosing a homogenizer for your lab.
July 30, 2025 -
3 min read
NGS
Cell-free DNA: dynamic regulation and NGS strategies for ultra-low-frequency variant detection.
July 28, 2025 -
7 min read
